$2.88 Billion is the total value of PLATINUM INVESTMENT MANAGEMENT LTD's 146 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TRU | New | TRANSUNION | $122,078,939 | – | 1,964,579 | +100.0% | 4.24% | – |
| NXPI | New | NXP SEMICONDUCTORS N V | $60,449,228 | – | 324,168 | +100.0% | 2.10% | – |
| CSL | New | CARLISLE COS INC | $55,738,689 | – | 246,555 | +100.0% | 1.94% | – |
| VAL | New | VALARIS LIMITEDcl a | $50,966,378 | – | 783,375 | +100.0% | 1.77% | – |
| PDD | New | PDD HOLDINGS INCsponsored ads | $28,054,765 | – | 369,628 | +100.0% | 0.97% | – |
| New | GE HEALTHCARE TECHNOLOGIES I | $23,943,983 | – | 291,893 | +100.0% | 0.83% | – | |
| SAGE | New | SAGE THERAPEUTICS INC | $3,185,603 | – | 75,920 | +100.0% | 0.11% | – |
| GOSS | New | GOSSAMER BIO INC | $2,977,594 | – | 2,363,170 | +100.0% | 0.10% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $1,935,683 | – | 76,208 | +100.0% | 0.07% | – |
| CF | New | CF INDS HLDGS INC | $1,457,629 | – | 20,108 | +100.0% | 0.05% | – |
| New | ORCHARD THERAPEUTICS PLCspon ads new | $639,717 | – | 119,128 | +100.0% | 0.02% | – | |
| VEEV | New | VEEVA SYS INC | $467,929 | – | 2,546 | +100.0% | 0.02% | – |
| New | STRUCTURE THERAPEUTICS INCsponsored ads | $356,850 | – | 15,000 | +100.0% | 0.01% | – | |
| NYCB | New | NEW YORK CMNTY BANCORP INC | $125,439 | – | 13,876 | +100.0% | 0.00% | – |
| BAX | New | BAXTER INTL INC | $87,528 | – | 2,158 | +100.0% | 0.00% | – |
| KSS | New | KOHLS CORP | $96,137 | – | 4,084 | +100.0% | 0.00% | – |
| New | JACKSON FINANCIAL INC | $94,834 | – | 2,535 | +100.0% | 0.00% | – | |
| MMM | New | 3M CO | $80,199 | – | 763 | +100.0% | 0.00% | – |
| TSN | New | TYSON FOODS INCcl a | $87,734 | – | 1,479 | +100.0% | 0.00% | – |
| CPRI | New | CAPRI HOLDINGS LIMITED | $98,888 | – | 2,104 | +100.0% | 0.00% | – |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $90,139 | – | 616 | +100.0% | 0.00% | – |
| TWLO | New | TWILIO INCcl a | $59,367 | – | 891 | +100.0% | 0.00% | – |
| JKHY | New | HENRY JACK & ASSOC INC | $58,027 | – | 385 | +100.0% | 0.00% | – |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $42,935 | – | 1,315 | +100.0% | 0.00% | – |
| New | MOBILEYE GLOBAL INC | $38,856 | – | 898 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTEL CORP | 42 | Q3 2023 | 8.3% |
| MICRON TECHNOLOGY INC | 42 | Q3 2023 | 9.1% |
| CISCO SYS INC | 42 | Q3 2023 | 6.9% |
| EBAY INC. | 39 | Q1 2023 | 5.9% |
| INFINITY PHARMACEUTICALS INC | 39 | Q4 2022 | 0.1% |
| SKYWORKS SOLUTIONS INC | 38 | Q3 2023 | 6.0% |
| ORACLE CORP | 38 | Q3 2023 | 7.8% |
| BARRICK GOLD CORPORATION | 37 | Q2 2022 | 5.4% |
| JD.COM INC | 36 | Q3 2023 | 2.8% |
| MICROSOFT CORP | 35 | Q3 2023 | 8.9% |
View PLATINUM INVESTMENT MANAGEMENT LTD's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ESPERION THERAPEUTICS INC/MI | February 10, 2022 | ? | ? |
| Centogene N.V. | December 09, 2021 | ? | ? |
| QIWI | February 19, 2019 | ? | ? |
| ALLEGHENY TECHNOLOGIES INC | February 15, 2017 | ? | ? |
| Fang Holdings Ltd | February 15, 2017 | ? | ? |
| SINA CORP | February 15, 2017 | ? | ? |
| Trina Solar LTD | February 15, 2017 | ? | ? |
| STILLWATER MINING CO /DE/ | January 11, 2017 | ? | ? |
| CIENA CORP | February 12, 2016 | ? | ? |
| KBR, INC. | February 12, 2016 | ? | ? |
View PLATINUM INVESTMENT MANAGEMENT LTD's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G | 2024-02-12 |
| SC 13G | 2024-02-12 |
| SC 13G | 2024-02-12 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-09 |
| 13F-HR | 2022-11-14 |
View PLATINUM INVESTMENT MANAGEMENT LTD's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.